Satellite: Innovations to Facilitate Acceleration of Voluntary Medical Male Circumcision Scale Up

Full Title: Innovations to Facilitate Acceleration of Voluntary Medical Male Circumcision Scale Up: Potential Role of Medical Devices

Date, Time and Location

Tuesday, July 24th
7:00 a.m. to 8:30 a.m.  
Mini Room 5

About This Session

This session will provide an introduction to devices and their potential to accelerate scale up, current stage of device research, and regulatory environment. The session will examine the clinical profiles and acceptability of devices, with an update on Shang Ring studies in Zambia & Kenya, as well as PrePex studies in Zimbabwe & Rwanda. The session will then address thinking ahead to device roll out: costing, global access, logistics, and training considerations, as well as leveraging the characteristics of devices to generate demand for VMMC. A panel discussion with device experts will follow.

Additional Background

Devices for adult and adolescent male circumcision that make the procedure quicker, simpler and less expensive have the potential to aid and accelerate scale up of male circumcision as a part of HIV Prevention Programs.


Support for this satellite session is provided by the:

  • U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
  • United States Department of Health and Human Services (HHS)
  • United States Centers for Disease Control (CDC)
  • United States Agency for International Development (USAID)
  • FHI 360
  • PSI
  • EngenderHealth
  • Jhpiego

Session Outline

Welcome and Introduction

  • Quarraisha Abdool Karim (CAPRISA)
  • Ward Cates (FHI 360)

Introduction to the Communications Handbook for Clinical Trials and The Role of Communication at Each Stage of a Trial Thomas Lent (FHI 360)

Case Study: When Communication Breaks Down

Case Study: What Works

Using the Handbook to Address Specific Communication Challenges: World Café Methodology

  • Facilitator: Thomas Lent

Participants will work in teams, using the handbook to address challenges at different stages of a trial. Teams will rotate 4-5 times every 10-15 minutes

  • Facilitator: Thomas Lent

What’s Next? Feedback on the Handbook and the Session